Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Increased expression of CD23 in rheumatoid synovitisHUISSOON, A. P ; EMERY, P ; BACON, P. A ; GORDON, J ; SALMON, MScandinavian journal of rheumatology, 2000, Vol.29 (3), p.154-159 [Periódico revisado por pares]Colchester: Informa UK LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))Emery, P ; Deodhar, A ; Rigby, W F ; Isaacs, J D ; Combe, B ; Racewicz, A J ; Latinis, K ; Abud-Mendoza, C ; Szczepański, L J ; Roschmann, R A ; Chen, A ; Armstrong, G K ; Douglass, W ; Tyrrell, HAnnals of the rheumatic diseases, 2010-09, Vol.69 (9), p.1629-1635 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
New therapies for treatment of rheumatoid arthritisSmolen, Josef S, Prof ; Aletaha, Daniel, MD ; Koeller, Marcus, MD ; Weisman, Michael H, MD ; Emery, Paul, ProfThe Lancet (British edition), 2007-12, Vol.370 (9602), p.1861-1874 [Periódico revisado por pares]London: Elsevier LtdTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trialGabay, Cem, MD ; Emery, Paul, MD ; van Vollenhoven, Ronald, MD ; Dikranian, Ara, MD ; Alten, Rieke, MD ; Pavelka, Karel, MD ; Klearman, Micki, MD ; Musselman, David, MD ; Agarwal, Sunil, MD ; Green, Jennifer, MSc ; Kavanaugh, Arthur, DrThe Lancet (British edition), 2013, Vol.381 (9877), p.1541-1550 [Periódico revisado por pares]Kidlington: Elsevier LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Combe, B ; Landewe, R ; Lukas, C ; Bolosiu, H D ; Breedveld, F ; Dougados, M ; Emery, P ; Ferraccioli, G ; Hazes, J M W ; Klareskog, L ; Machold, K ; Martin-Mola, E ; Nielsen, H ; Silman, A ; Smolen, J ; Yazici, HAnnals of the rheumatic diseases, 2007-01, Vol.66 (1), p.34-45 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trialSmolen, Josef S, Prof ; Emery, Paul, Prof ; Fleischmann, Roy, Prof ; van Vollenhoven, Ronald F, Prof ; Pavelka, Karel, Prof ; Durez, Patrick, Prof ; Guérette, Benoît, PhD ; Kupper, Hartmut, MD ; Redden, Laura, MD ; Arora, Vipin, PhD ; Kavanaugh, Arthur, ProfThe Lancet (British edition), 2014-01, Vol.383 (9914), p.321-332 [Periódico revisado por pares]Kidlington: Elsevier LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trialEmery, P ; Keystone, E ; Tony, H P ; Cantagrel, A ; van Vollenhoven, R ; Sanchez, A ; Alecock, E ; Lee, J ; Kremer, JAnnals of the rheumatic diseases, 2008-11, Vol.67 (11), p.1516-1523 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb studyWEINBLATT, Michael E ; FLEISCHMANN, Roy ; GOEL, Niti ; DAVIES, Owen R ; DOUGADOS, Maxime ; HUIZINGA, Tom W. J ; EMERY, Paul ; POPE, Janet ; MASSAROTTI, Elena M ; VOLLENHOVEN, Ronald F. Van ; WOLLENHAUPT, Jürgen ; BINGHAM, Clifton O ; DUNCAN, BenRheumatology (Oxford, England), 2012-12, Vol.51 (12), p.2204-2214 [Periódico revisado por pares]Oxford: Oxford University PressTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological Report Phase IFunovits, Julia ; Aletaha, Daniel ; Bykerk, Vivian ; Combe, Bernard ; Dougados, Maxime ; Emery, Paul ; Felson, David ; Hawker, Gillian ; Hazes, Joanna M ; Huizinga, Tom ; Kay, Jonathan ; Kvien, Tore K ; Smolen, Josef S ; Symmons, Deborah ; Tak, Paul P ; Silman, AlanAnnals of the rheumatic diseases, 2010-09, Vol.69 (9), p.1589-1595 [Periódico revisado por pares]London: BMJ Publishing Group Ltd and European League Against RheumatismTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
A simplified disease activity index for rheumatoid arthritis for use in clinical practiceSmolen, J. S. ; Breedveld, F. C. ; Schiff, M. H. ; Kalden, J. R. ; Emery, P. ; Eberl, G. ; van Riel, P. L. ; Tugwell, P.Rheumatology (Oxford, England), 2003-02, Vol.42 (2), p.244-257 [Periódico revisado por pares]Oxford: Oxford University PressTexto completo disponível |